Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
H.B. Fuller
FUL
$3.11B
| $9.82M | ﹤0.01% |
137,266
+81,856
| +148% | +$5.38M |
|
2002
MoonLake Immunotherapeutics
MLTX
$1.31B
| $9.81M | ﹤0.01% |
192,404
+157,333
| +449% | +$4.23M |
|
2003
Brown-Forman Class B
BF.B
$12.8B
| $9.81M | ﹤0.01% |
146,932
-338,573
| -70% | -$21.7M |
|
2004
Welltower
WELL
$174B
| $9.8M | ﹤0.01% |
121,129
-385,948
| -76% | -$29.7M |
|
2005
Archer Daniels Midland
ADM
$38.5B
| $9.79M | ﹤0.01% |
129,595
+31,403
| +32% | +$2.38M |
|
|
MPT
2006
Medical Properties Trust
MPT
$2.46B
| $9.78M | ﹤0.01% |
+1,056,151
| New | +$8.93M |
|
2007
United Natural Foods
UNFI
$2.9B
| $9.78M | ﹤0.01% |
500,125
-298,120
| -37% | -$7.49M |
|
|
ESMT
2008
CALL
DELISTED
EngageSmart, Inc.
ESMT
| $9.77M | ﹤0.01% |
+511,700
| New | +$9.1M |
|
2009
CALL
Suncor Energy
SU
$77.3B
| $9.76M | ﹤0.01% |
+251,700
| New | +$7.53M |
|
|
ACRE
2010
Ares Commercial Real Estate
ACRE
$259M
| $9.75M | ﹤0.01% |
960,390
+126,392
| +15% | +$1.15M |
|
2011
Simpson Manufacturing
SSD
$7.61B
| $9.74M | ﹤0.01% |
70,301
+58,880
| +516% | +$7.24M |
|
|
TDAY
2012
USA Today Co
TDAY
$953M
| $9.72M | ﹤0.01% |
4,322,175
+4,063,449
| +1,571% | +$8.11M |
|
2013
Protagonist Therapeutics
PTGX
$9.73B
| $9.72M | ﹤0.01% |
351,810
-770,532
| -69% | -$19.3M |
|
2014
Powell Industries
POWL
$7.03B
| $9.69M | ﹤0.01% |
479,745
-227,484
| -32% | -$3.94M |
|
2015
PUT
Chewy
CHWY
$9.58B
| $9.68M | ﹤0.01% |
245,200
+32,100
| +15% | +$1.12M |
|
2016
CALL
Synopsys
SNPS
$78.3B
| $9.67M | ﹤0.01% |
+22,200
| New | +$8.94M |
|
|
MTLS
2017
Materialise
MTLS
$378M
| $9.65M | ﹤0.01% |
1,117,262
+187,862
| +20% | +$1.62M |
|
|
KAMN
2018
DELISTED
Kaman Corp
KAMN
| $9.65M | ﹤0.01% |
396,491
+311,228
| +365% | +$7.03M |
|
2019
CALL
Sempra
SRE
$55.7B
| $9.64M | ﹤0.01% |
132,400
-86,200
| -39% | -$6.47M |
|
|
SLCA
2020
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $9.61M | ﹤0.01% |
792,398
-727,090
| -48% | -$8.98M |
|
2021
Travere Therapeutics
TVTX
$6.27B
| $9.59M | ﹤0.01% |
624,603
-499,735
| -44% | -$9.09M |
|
2022
American Vanguard Corp
AVD
$66.7M
| $9.56M | ﹤0.01% |
535,254
+369,105
| +222% | +$6.82M |
|
2023
PUT
Teradyne
TER
$56.9B
| $9.56M | ﹤0.01% |
85,900
+27,600
| +47% | +$2.77M |
|
|
HWEL
2024
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
| $9.56M | ﹤0.01% |
930,000
| – | – |
|
2025
SITE Centers
SITC
$158M
| $9.56M | ﹤0.01% |
926,698
+42,965
| +5% | +$410K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.